Sou Hu Cai Jing·2025-08-20 11:28Group 1 - The core viewpoint of the articles highlights the performance and valuation of Spring Medical, which has a current stock price of 23.29 yuan, a PE ratio of 69.87, and a total market capitalization of 8.933 billion yuan [1][2] - The average PE ratio for the medical device industry is 59.32, with a median of 39.97, positioning Spring Medical at the 93rd rank within the industry [1][2] - As of March 31, 2025, Spring Medical has 7,167 shareholders, an increase of 501 from the previous count, with an average holding value of 352,800 yuan and an average shareholding of 27,600 shares [1] Group 2 - Spring Medical specializes in the research, production, and sales of implantable orthopedic medical devices, including spinal, trauma, joint, sports medicine, bone repair materials, surgical instruments, and PRP preparation kits [1] - The latest quarterly report for Q1 2025 shows that the company achieved a revenue of 230 million yuan, a year-on-year increase of 3.60%, and a net profit of 58.071 million yuan, reflecting a year-on-year increase of 5.20%, with a gross margin of 66.69% [1]